SEARCH

SEARCH BY CITATION

References

  • Behar, K.L., Rothman, D.L., Petersen, K.F., Hooten, M., Delaney, R., Petroff, O.A.C., Shulman, G.I., Navarro, V., Petrakis, I.L., Charney, D.S. & Krystal, J.H. (1999) Preliminary evidence of low cortical GABA levels in localized H-1-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry 156, 952954.
  • Benjamin, J., Levine, J., Fux, M., Aviv, A., Levy, D. & Belmaker, R.H. (1995) Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 152, 10841086.
  • Bogdanov, M., Matson, W.R., Wang, L., Matson, T., Saunders-Pullman, R., Bressman, S.S. & Beal, M.F. (2008) Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 131, 389396.
  • Bowery, N.G. & Brown, D.A. (1974) Depolarizing actions of gamma-aminobutyric acid and related compounds on rat superior cervical ganglia in-vitro. Br J Pharmacol 50, 205218.
  • Brodie, J.D., Figueroa, E., Laska, E.M. & Dewey, S.L. (2005) Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction. Synapse 55, 122125.
  • Chen, R., Zhang, M., Park, S. & Gnegy, M.E. (2007) C57BL/6J mice show greater amphetamine-induced locomotor activation and dopamine efflux in the striatum than 129S2/SvHsd mice. Pharmacol Biochem Behav 87, 158163.
  • Cohen, H., Kotler, M., Kaplan, Z., Matar, M.A., Kofman, O. & Belmaker, R.H. (1997) Inositol has behavioral effects with adaptation after chronic administration. J Neural Transm 104, 299305.
  • Cohen, P., Cohen, J.B., West, S.J. & Aiken, L.S. (2003) Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. L. Erlbaum Associates, Mahwah, NJ.
  • De Graaf, R.A., Chowdhury, G.M.I., Brown, P.B., Rothman, D.L. & Behar, K.L. (2009) In situ 3D magnetic resonance metabolic imaging of microwave-irradiated rodent brain: a new tool for metabolomics research. J Neurochem 109, 494501.
  • Dewey, S.L., Smith, G.S., Logan, J., Brodie, J.D., Yu, D.W., Ferrieri, R.A., King, P.T., Macgregor, R.R., Martin, T.P., Wolf, A.P., Volkow, N.D., Fowler, J.S. & Meller, E. (1992) Gabaergic inhibition of endogenous dopamine release measured in vivo with C-11 raclopride and positron emission tomography. J Neurosci 12, 37733780.
  • Dunn, W.B., Broadhurst, D.I., Atherton, H.J., Goodacre, R. & Griffin, J.L. (2011) Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 40, 387426.
  • Einat, H. & Belmaker, R.H. (2001) The effects of inositol treatment in animal models of psychiatric disorders. J Affect Disord 62, 113121.
  • Eisener-Dorman, A.F., Grabowski-Boase, L. & Tarantino, L.M. (2011) Cocaine locomotor activation, sensitization and place preference in six inbred strains of mice. Behav Brain Funct 7.
  • Evans, A.M., DeHaven, C.D., Barrett, T., Mitchell, M. & Milgram, E. (2009) Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 81, 66566667.
  • Fernando, R.L., Nettleton, D., Southey, B.R., Dekkers, J.C., Rothschild, M.F. & Soller, M. (2004) Controlling the proportion of false positives in multiple dependent tests. Genetics 166, 611619.
  • Flint, J. & Eskin, E. (2012) Genome-wide association studies in mice. Nat Rev Genet 13, 807817.
  • Gerasimov, M.R., Ashby, C.R., Gardner, E.L., Mills, M.J., Brodie, J.D. & Dewey, S.L. (1999) Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse 34, 1119.
  • Goddard, A.W., Mason, G.F., Almai, A., Rothman, D.L., Behar, K.L., Petroff, O.A.C., Charney, D.S. & Krystal, J.H. (2001) Reductions in occipital cortex GABA levels in panic disorder detected with H-1-magnetic resonance spectroscopy. Arch Gen Psychiatry 58, 556561.
  • Ikarashi, Y., Sasahara, T. & Maruyama, Y. (1985) Postmortem changes in catecholamines, indoleamines, and their metabolites in rat-brain regions—prevention with 10-Kw microwave irradiation. J Neurochem 45, 935939.
  • Institute of Laboratory Animal Research (1996) Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC.
  • Iraqi, F.A., Mahajne, M., Salaymah, Y. et al. (2012) The genome architecture of the collaborative cross mouse genetic reference population. Genetics 190, 389401.
  • Jackson, M.C., Scollard, D.M., Mack, R.J. & Lenney, J.F. (1994) Localization of a novel pathway for the liberation of GABA in the human CNS. Brain Res Bull 33, 379385.
  • Jansen, E.E.W., Verhoeven, N.M., Cornelis, J.A., Schulze, A., Senephansiri, H., Gupta, M., Snead, O.C. & Gibson, K.M. (2006) Increased guanidino species in murine and human succinate semialdehyde dehydrogenase (SSADH) deficiency. Biochim Biophys Acta Mol Basis Dis 1762, 494498.
  • Kaddurah-Daouk, R. & Krishnan, K.R. (2009) Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 34, 173186.
  • Kim, H., McGrath, B.M. & Silverstone, P.H. (2005) A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders—focus on magnetic resonance spectroscopy (MRS) studies. Hum Psychopharmacol Clin Exp 20, 309326.
  • Login, G.R. & Dvorak, A.M. (1994) Application of microwave fixation techniques in pathology to neuroscience studies: a review. J Neurosci Methods 55, 173182.
  • McClay, J., Adkins, D., Vunck, S., Batman, A., Vann, R., Clark, S., Beardsley, P. & Oord, E.C.G. (2013) Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure. Metabolomics 9, 392402.
  • Mead, A.N., Katz, J.L. & Rocha, B.A. (2002) Intravenous cocaine-induced activity in A/J and C57BL/6J mice: behavioral sensitization and conditioned activity. Neuropharmacology 42, 976986.
  • Nestler, E.J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2, 119128.
  • Nguyen, Q., Sapp, D.W., Vanness, P.C. & Olsen, R.W. (1995) Modulation of GABA(A) receptor-binding in human brain by neuroactive steroids—species and brain regional differences. Synapse 19, 7787.
  • Niwa, M., Yan, Y. & Nabeshima, T. (2008) Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction. Ann N Y Acad Sci 1141, 7695.
  • Ohta, T., Masutomi, N., Tsutsui, N., Sakairi, T., Mitchell, M., Milburn, M.V., Ryals, J.A., Beebe, K.D. & Guo, L. (2009) Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol Pathol 37, 521535.
  • van den Oord, E. & Sullivan, P.F. (2003) False discoveries and models for gene discovery. Trends Genet 19, 537542.
  • Peachey, J.E., Rogers, B., Brien, J.F., Maclean, A. & Rogers, D. (1976) Measurement of acute and chronic behavioral-effects of methamphetamine in mouse. Psychopharmacology (Berl) 48, 271275.
  • Pears, M.R., Cooper, J.D., Mitchison, H.M., Mortishire-Smith, R.J., Pearce, D.A. & Griffin, J.L. (2005) High resolution (1)H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease. J Biol Chem 280, 4250842514.
  • Peters, L.L., Robledo, R.F., Bult, C.J., Churchill, G.A., Paigen, B.J. & Svenson, K.L. (2007) The mouse as a model for human biology: a resource guide for complex trait analysis. Nat Rev Genet 8, 5869.
  • Petroff, O.A.C. (2002) GABA and glutamate in the human brain. Neuroscientist 8, 562573.
  • Petroff, O.A. & Williamson, A. (2009) Homocarnosine enhances inhibitory tone in rat hippocampus. Ann Neurol 66, S14S.
  • Petroff, O.A., Hyder, F., Rothman, D.L. & Mattson, R.H. (1998a) Human brain GABA and homocarnosine increased after starting topiramate. Neurology 50, A312A.
  • Petroff, O.A.C., Mattson, R.H., Behar, K.L., Hyder, F. & Rothman, D.L. (1998b) Vigabatrin increases human brain homocarnosine and improves seizure control. Ann Neurol 44, 948952.
  • Petroff, O.A.C., Hyder, F., Collins, T., Mattson, R.H. & Rothman, D.L. (1999) Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures. Epilepsia 40, 958964.
  • Philip, V.M., Duvvuru, S., Gomero, B., Ansah, T.A., Blaha, C.D., Cook, M.N., Hamre, K.M., Lariviere, W.R., Matthews, D.B., Mittleman, G., Goldowitz, D. & Chesler, E.J. (2010) High-throughput behavioral phenotyping in the expanded panel of BXD recombinant inbred strains. Genes Brain Behav 9, 129159.
  • Pierce, R.C. & Kalivas, P.W. (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25, 192216.
  • Prabakaran, S., Swatton, J.E., Ryan, M.M., Huffaker, S.J., Huang, J.T.J., Griffin, J.L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K.S., Karp, N.A., Hester, S., Tkachev, D., Mimmack, M.L., Yolken, R.H., Webster, M.J., Torrey, E.F. & Bahn, S. (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9, 684697.
  • Robinson, G.K. (1991) That BLUP is a good thing: the estimation of random effects. Stat Sci 6, 1532.
  • Robinson, T.E. & Berridge, K.C. (2008) The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc B Biol Sci 363, 31373146.
  • Rogers, W. (1994) Regression standard errors in clustered samples. Stata Tech Bull 3, 1923.
  • Schulze, A., Mayatepek, E., Frank, S., Marescau, B., De Deyn, P.P. & Bachert, P. (1998) Disturbed metabolism of guanidino compounds characterized by elevated excretion of beta-guanidinopropionic acid and gamma-guanidinobutyric acid—an effect of vigabatrin treatment? J Inherit Metab Dis 21, 268271.
  • Shimon, H., Agam, G., Belmaker, R.H., Hyde, T.M. & Kleinman, J.E. (1997) Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry 154, 11481150.
  • Simon, P., Dupuis, R. & Costentin, J. (1994) Thigmotaxis as an index of anxiety in mice—influence of dopaminergic transmissions. Behav Brain Res 61, 5964.
  • Snider, S.E., Vunck, S.A., van den Oord, E., Adkins, D.E., McClay, J.L. & Beardsley, P.M. (2012) The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice. Eur J Pharmacol 679, 7580.
  • Steketee, J.D. (2003) Neurotransmitter systems of the medial prefrontal cortex: potential role in sensitization to psychostimulants. Brain Res Rev 41, 203228.
  • Steketee, J.D. & Kalivas, P.W. (2011) Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev 63, 348365.
  • Storey, J. (2003) The positive false discovery rate: a Bayesian interpretation and the q-value. Ann Stat 31, 20132035.
  • Strakowski, S.M. & Sax, K.W. (1998) Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans. Biol Psychiatry 44, 11711177.
  • Thomsen, M. & Caine, S.B. (2011) Psychomotor stimulant effects of cocaine in rats and 15 mouse strains. Exp Clin Psychopharmacol 19, 321341.
  • Willett, J.B. (1989) Some results on reliability for the longitudinal measurement of change—implications for the design of studies of individual growth. Educ Psychol Meas 49, 587602.
  • Willett, J.B., Singer, J.D. & Martin, N.C. (1998) The design and analysis of longitudinal studies of development and psychopathology in context: statistical models and methodological recommendations. Dev Psychopathol 10, 395426.
  • Williams, R.L. (2000) A note on robust variance estimation for cluster-correlated data. Biometrics 56, 645646.
  • Wise, R.A. & Bozarth, M.A. (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94, 469492.
  • Yang, H., Bell, T.A., Churchill, G.A. & de Villena, F.P.M. (2007) On the subspecific origin of the laboratory mouse. Nat Genet 39, 11001107.
  • Zhang, L., Kitaichi, K., Fujimoto, Y., Nakayama, H., Shimizu, E., Iyo, M. & Hashimoto, K. (2006) Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry 30, 13811393.